Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.074 | 0.09 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.09 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.09 | 0.09 |
mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.31 | 0.09 |
mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |